Skip to main content
. Author manuscript; available in PMC: 2022 Dec 1.
Published in final edited form as: Lancet Glob Health. 2022 Dec;10(12):e1815–e1824. doi: 10.1016/S2214-109X(22)00413-2

Figure 1: Study profile.

Figure 1:

Exclusion criteria were applied independently and patients could have met several exclusion criteria; therefore disaggregated exclusion criteria numbers do not sum to the total number of patients excluded. ART=antiretroviral therapy. VLNS=virological non-suppression. *Non-standard regimens include ART combinations other than nucleos(t)ide reverse transcriptase inhibitor plus non-nucleoside reverse transcriptase inhibitor, nucleos(t)ide reverse transcriptase inhibitor plus integrase strand transfer inhibitor, or nucleos(t)ide reverse transcriptase inhibitor plus protease inhibitor. Insufficiently potent ART denotes monotherapy or dual therapy.